2seventy bio, Inc. (NASDAQ: TSVT) reported Q1 EPS of ($1.01), $0.26 worse than the analyst estimate of ($0.75). Revenue for the quarter came in at $12.4 million versus the consensus estimate of $14.8 million.

For earnings history and earnings-related data on 2seventy bio, Inc. (TSVT) click here.